Regulation of the dephosphorylation of Stat6 -: Participation of TYR-713 in the interleukin-4 receptor α, the tyrosine phosphatase SHP-1, and the proteasome

被引:56
作者
Hanson, EM
Dickensheets, H
Qu, CK
Donnelly, RP
Keegan, AD
机构
[1] Amer Red Cross, Holland Lab, Dept Immunol, Rockville, MD 20855 USA
[2] Amer Red Cross, Holland Lab, Dept Hematopoiesis, Rockville, MD 20855 USA
[3] Fed Drug Adm, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA
[4] George Washington Univ, Ctr Med, Inst Biomed Sci, Bethesda, MD 20892 USA
关键词
D O I
10.1074/jbc.M211747200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Signal transducer and activator of transcription 6 (Stat6) plays an important role in interleukin (IL)-4-induced responses. To analyze the regulation of Stat6 phosphorylation, cells were cultured in the continuous presence of IL-4 or after a pulse and washout. In the continual presence of IL-4, Stat6 remained phosphorylated for an extended period. After IL-4 removal and inhibition of the Janus family kinase, tyrosine-phosphorylated Stat6 decayed at a rate dependent upon the length of IL-4 stimulation. The decay of tyrosine-phosphorylated Stat6 was similar in the presence or absence of either cycloheximide or actinomycin D. In the absence of functional Src homology-containing phosphatase-1 (SHP-1), the early loss of tyrosine-phosphorylated Stat6 was substantially reduced. Furthermore, the rate of loss of tyrosine-phosphorylated Stat6 in cells expressing a mutation of the human IL-4 receptor a in the immunoreceptor tyrosine-based inhibitory motif sequence (Y5F) was dramatically decreased compared with wild-type cells. The early rate of decay was similar in the presence or absence of MG132, an inhibitor of the proteasome, but the later rate of decay was decreased 5-fold. These results suggest that the loss of tyrosine phosphorylation of Stat6 is regulated by the action of SHP-1 and the proteasome but is not dependent on new protein synthesis.
引用
收藏
页码:3903 / 3911
页数:9
相关论文
共 50 条
  • [41] MUTATIONS AT THE MURINE MOTH-EATEN LOCUS ARE WITHIN THE HEMATOPOIETIC-CELL PROTEIN-TYROSINE-PHOSPHATASE (HCPH) GENE
    SHULTZ, LD
    SCHWEITZER, PA
    RAJAN, TV
    YI, TL
    IHLE, JN
    MATTHEWS, RJ
    THOMAS, ML
    BEIER, DR
    [J]. CELL, 1993, 73 (07) : 1445 - 1454
  • [42] DIFFERENTIAL REGULATION OF IGG1 AND IGE SYNTHESIS BY INTERLEUKIN-4
    SNAPPER, CM
    FINKELMAN, FD
    PAUL, WE
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (01) : 183 - 196
  • [43] A family of cytokine-inducible inhibitors of signalling
    Starr, R
    Willson, TA
    Viney, EM
    Murray, LJL
    Rayner, JR
    Jenkins, BJ
    Gonda, TJ
    Alexander, WS
    Metcalf, D
    Nicola, NA
    Hilton, DJ
    [J]. NATURE, 1997, 387 (6636) : 917 - 921
  • [44] TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124
  • [45] A small amphipathic α-helical region is required for transcriptional activities and proteasome-dependent turnover of the tyrosine-phosphorylated Stat5
    Wang, DM
    Moriggl, R
    Stravopodis, D
    Carpino, N
    Marine, JC
    Teglund, S
    Feng, JA
    Ihle, JN
    [J]. EMBO JOURNAL, 2000, 19 (03) : 392 - 399
  • [46] Wang HY, 1999, J IMMUNOL, V162, P4385
  • [47] White ED, 2001, J LEUKOCYTE BIOL, V69, P825
  • [48] Negative regulation of cytokine signaling pathways
    Yasukawa, H
    Sasaki, A
    Yoshimura, A
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 : 143 - 164
  • [49] Cytosolic tyrosine dephosphorylation of STAT5 - Potential role of SHP-2 in STAT5 regulation
    Yu, CL
    Jin, YJ
    Burakoff, SJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (01) : 599 - 604
  • [50] Zamorano J, 1998, J IMMUNOL, V161, P859